1.5 ml semaglutide The Indian government has approved #NovoNordisk's obesity drug, Wegovy, for the treatment of #fattyliver disease. Novo Nordisk said the Central Drugs Standard Control Organisation (CDSCO) approved #Wegovy's 2.4 mg injection for SEMAGLUTIDE PEPTIDE VIAL – UMBRELLA
Pay in 4 interest-free payments of $5.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27


















00226-8/asset/6fb2a82a-3829-4742-96c8-70e9d464ea34/main.assets/gr2.jpg)




